title: [The study of effects of ramipril and amlodipine combination in patients with arterial hypertension and type 2 diabetes mellitus].
authors.forename: O N
authors.initials: ON
authors.lastname: Tkacheva
authors.forename: A V
authors.initials: AV
authors.lastname: Barabashkina
authors.forename: I M
authors.initials: IM
authors.lastname: Novikova
authors.forename: N K
authors.initials: NK
authors.lastname: Runikhina
mesh_terms: D000328:Adult; D000368:Aged; D017311:Amlodipine / Q000008:administration & dosage*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage*; D001794:Blood Pressure / Q000187:drug effects* / Q000502:physiology; D018660:Blood Pressure Monitoring, Ambulatory; D002121:Calcium Channel Blockers / Q000008:administration & dosage*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D017257:Ramipril / Q000008:administration & dosage*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D017311:Amlodipine; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D006442:Glycated Hemoglobin; D017257:Ramipril